Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventive Therapy for Tuberculosis in HIV Infected Persons
NCT00351702Phase 3Completed
- Sponsor
- National Institute for Research in Tuberculosis
- Start
- Feb 2001
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Tuberculosis (TB) comparing Isoniazid + Ethambutol with Isoniazid (2 arms). Primary endpoint: Development of tuberculosis at 36 months. Started Feb 2001; status: completed.
02
Drugs
ethambutolisoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00351702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00351702.